
Treatment Outcomes of Colistin- And Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial
By: Dickstein Y., Lellouche J., Ben Dalak Amar M., Schwartz D., Nutman A., Daitch V., Yahav D., Leibovici L., Skiada A., Antoniadou A., Daikos G.L., Andini R., Zampino R., Durante-Mangoni E., Mouton J.W., Friberg L.E., Dishon Benattar Y., Bitterman R., Neuberger A., Carmeli Y., Paul M., Zayyad H., Koppel F., Zak-Doron Y., Altunin S., Andria N., Stern A., Petersiel N., Raines M., Karban A., Eliakim-Raz N., Zusman O., Elbaz M., Atamna H., Babich T., Adler A., Levi I., Pavleas I., Kotsaki A., Iossa D., Bernardo M., Cavezza G., Bertolino L., Giuffre G., Giurazza R., Cuccurullo S., Galdo M., Murino P., Cristinziano A., Corcione A., Clara Pafundi P.
Published in: Clinical Infectious Diseases
SDGs : SDG 03 | Units: | Time: 2019 | Link
Description: Background: We evaluated the association between mortality and colistin resistance in Acinetobacter baumannii infections (more…)